Syapse
Syapse, Genesis Research Partner to Offer Expanded Oncology Real-World Evidence Services
The real-world evidence firms will begin comarketing services to pharma clients developing biomarker-directed oncology drugs in the coming months.
Syapse Raises $35M in Venture Capital Funding
The precision oncology software company will continue to expand its network of partners to improve outcomes for cancer patients in community healthcare settings.
Illumina, Syapse Partner on Study of Comprehensive Genomic Profiling in Advanced Cancer
Syapse will analyze data from single-gene, small panel, and comprehensive genomic profiling tests in the community oncology setting, with input from Illumina.
In Brief This Week: OnKure, Inovio, Syapse, Genetron Health
News items for the week of Dec. 13, 2021.
Real-World Data Points to Racial Disparity in BRCA1/2 Testing Among TNBC Patients
Researchers analyzed data from Syapse's Learning Health Network and found that more Black patients were unable to be tested or declined it compared to white patients.
Feb 24, 2021
Feb 2, 2021
Syapse Raises $68M in Equity Financing
May 28, 2020
Syapse Raises $30M in Equity Funding
Dec 6, 2019
Roche Ending Partnership With Syapse
May 3, 2019
Amgen, Syapse Collaborate on Precision Oncology
May 14, 2018